NO954414L - Transdermal therapeutic systems for administration of serotonin agonists - Google Patents

Transdermal therapeutic systems for administration of serotonin agonists

Info

Publication number
NO954414L
NO954414L NO954414A NO954414A NO954414L NO 954414 L NO954414 L NO 954414L NO 954414 A NO954414 A NO 954414A NO 954414 A NO954414 A NO 954414A NO 954414 L NO954414 L NO 954414L
Authority
NO
Norway
Prior art keywords
administration
transdermal therapeutic
therapeutic systems
serotonin agonists
active substances
Prior art date
Application number
NO954414A
Other languages
Norwegian (no)
Other versions
NO954414D0 (en
Inventor
Harald List
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO954414D0 publication Critical patent/NO954414D0/en
Publication of NO954414L publication Critical patent/NO954414L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

The invention concerns a transdermal therapeutic system for the systemic administration of active substances, the system being characterized in that at least one of the active substances is a serotonin agonist selected from the indole derivatives, e.g. sumatriptan.
NO954414A 1993-05-06 1995-11-03 Transdermal therapeutic systems for administration of serotonin agonists NO954414L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4314976A DE4314976C1 (en) 1993-05-06 1993-05-06 Transdermal therapeutic systems for the administration of drugs, process for their production and their use
PCT/EP1994/001280 WO1994026270A1 (en) 1993-05-06 1994-04-25 Transdermal therapeutic systems for the administration of serotonin agonists

Publications (2)

Publication Number Publication Date
NO954414D0 NO954414D0 (en) 1995-11-03
NO954414L true NO954414L (en) 1995-11-03

Family

ID=6487316

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954414A NO954414L (en) 1993-05-06 1995-11-03 Transdermal therapeutic systems for administration of serotonin agonists

Country Status (20)

Country Link
EP (1) EP0697869B1 (en)
JP (1) JPH08509749A (en)
KR (1) KR960702306A (en)
AT (1) ATE183392T1 (en)
AU (1) AU686159B2 (en)
CA (1) CA2160776A1 (en)
CZ (1) CZ289395A3 (en)
DE (2) DE4314976C1 (en)
DK (1) DK0697869T3 (en)
ES (1) ES2138659T3 (en)
FI (1) FI955260A (en)
GR (1) GR3031639T3 (en)
HU (1) HUT74865A (en)
IL (1) IL109509A (en)
NO (1) NO954414L (en)
NZ (1) NZ265949A (en)
PL (1) PL179353B1 (en)
SK (1) SK138095A3 (en)
WO (1) WO1994026270A1 (en)
ZA (1) ZA942872B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9509985A (en) * 1995-12-12 1998-11-03 Omeros Med Sys Inc Solution for irrigation and method for inhibiting pain, inflammation and sparse
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
EP1170006B8 (en) * 1999-12-14 2008-03-19 Teikoku Seiyaku Co., Ltd. Drug for alleviating migraine
ATE404193T1 (en) * 2001-06-05 2008-08-15 Ronald Aung-Din TOPICAL MIGRAINE THERAPY
US8329734B2 (en) 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
US7332183B2 (en) 2002-12-26 2008-02-19 Pozen Inc. Multilayer dosage forms containing NSAIDs and triptans
US20070065463A1 (en) 2003-06-20 2007-03-22 Ronald Aung-Din Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
EP1962837A4 (en) 2005-12-20 2011-12-14 Teikoku Pharma Usa Inc Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same
CN104138634B (en) 2006-04-13 2016-09-07 梯瓦制药国际有限责任公司 The transdermal methods of delivery of anti-migraine compounds and system
JP2011526889A (en) 2008-06-30 2011-10-20 アフギン ファーマ,エルエルシー Local nerve action therapy
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
US9211282B2 (en) 2009-09-25 2015-12-15 Dr. Reddy's Laboratories Ltd. Formulations comprising triptan compounds
JP6216151B2 (en) * 2013-04-19 2017-10-18 コスメディ製薬株式会社 Hydrophilic drug emulsion patch
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
US20160256410A1 (en) 2015-03-02 2016-09-08 Afgin Pharma, Llc Topical regional neuro-affective therapy in mammals with cannabinoids
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
WO1992000103A1 (en) * 1990-06-28 1992-01-09 Beecham Group Plc Pharmaceutical preparations
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
GB9104890D0 (en) * 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions

Also Published As

Publication number Publication date
CZ289395A3 (en) 1996-04-17
DE59408643D1 (en) 1999-09-23
PL179353B1 (en) 2000-08-31
IL109509A (en) 1999-12-22
AU686159B2 (en) 1998-02-05
ATE183392T1 (en) 1999-09-15
HU9503167D0 (en) 1996-01-29
FI955260A (en) 1995-11-17
WO1994026270A1 (en) 1994-11-24
AU6648094A (en) 1994-12-12
EP0697869B1 (en) 1999-08-18
JPH08509749A (en) 1996-10-15
KR960702306A (en) 1996-04-27
NZ265949A (en) 1997-10-24
SK138095A3 (en) 1996-06-05
NO954414D0 (en) 1995-11-03
ES2138659T3 (en) 2000-01-16
CA2160776A1 (en) 1994-11-24
DE4314976C1 (en) 1994-10-06
HUT74865A (en) 1997-02-28
IL109509A0 (en) 1994-08-26
ZA942872B (en) 1995-07-06
DK0697869T3 (en) 2000-03-20
FI955260A0 (en) 1995-11-02
GR3031639T3 (en) 2000-02-29
EP0697869A1 (en) 1996-02-28
PL311591A1 (en) 1996-02-19

Similar Documents

Publication Publication Date Title
NO954414D0 (en) Transdermal therapeutic systems for administration of serotonin agonists
MX9207263A (en) SYSTEM FOR THE SUPPLY OF AN ACTIVE SUBSTANCE FOR SUSTAINED LIBERATION.
DE69527509D1 (en) HYDROGEL FORMULATION WITH CONTROLLED RELEASE
FI930862A0 (en) EN DOSERINGSFORM FOER TIDSVARIERANDE MOENSTER AV LAEKEMEDELOEVERLAOTELSE
MA26456A1 (en) PHARMACEUTICAL FORMULATIONS FOR THE EXTENDED DELIVERY OF MEDICAMENT.
NO911260D0 (en) DELIVERY SYSTEM FOR ARMASTIC AND SWEATING AGENTS, AND PROCEDURE FOR THE PREPARATION OF SUCH A SYSTEM.
FI943280A0 (en) Osmotic apparatus with delayed activation of drug distribution
AU4989997A (en) Soluble form osmotic dose delivery system
MX9300014A (en) NEW DERIVATIVES OF 1,2,4-TRIAMINOBENZENE AND PROCESS FOR ITS PREPARATION.
NO943762D0 (en) Indole derivatives such as 5-HT 1 agonists
NO305906B1 (en) Adhesion receptor antagonists, pharmaceutical preparations containing such compounds, and the use of the compounds for the manufacture of drugs.
NO991405L (en) Coated particle formulation
ES2166988T3 (en) UNIFORM ADMINISTRATION THERAPY OF PHARMACOS.
DK0825857T3 (en) Use of gabapentin and its derivatives for the treatment of mania and bipolar disorder
BR9608255A (en) Transdermal therapeutic system (stt) for testosterone administration
NO954287L (en) Use of indole derivatives as 5-HT1 agonists
NO306113B1 (en) Adhesion receptor antagonists, pharmaceutical preparations containing such compounds, and the use of the compounds for the manufacture of drugs.
NO305836B1 (en) Oxazolidin-2-one compounds, pharmaceutical preparations containing at least one such compound, and the use of the compounds for the manufacture of pharmaceuticals
ATE211383T1 (en) TOPICAL ACICLOVIR PREPARATION
ES2186909T3 (en) ANTIPALUDIC AGENTS AND ANTIBABESIOSIS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
SI0697869T1 (en) Transdermal therapeutic systems for the administration of serotonin agonists
NO931208L (en) FORMULATIONS FOR TRANSDERMAL CONTRASE OPTIVES, AND PROCEDURES AND DEVICES FOR SUPPLYING SUCH
DE69615340D1 (en) ANTIMYCOTIC COMPOSITION WHICH CONTAINS CROTAMITON AND SALICYLALDEHYDE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application